Stock ALDX ALDEYRA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Aldeyra Therapeutics, Inc.

Equities

ALDX

US01438T1060

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-09 pm EDT 		5-day change 1st Jan Change
3.94 USD -3.19% Intraday chart for Aldeyra Therapeutics, Inc. -6.41% +12.25%
May. 08 Aldeyra Therapeutics Enrolls First Patient in Phase 3 Dry Eye Chamber Study MT
May. 08 Aldeyra Therapeutics, Inc. Enrolls First Patient in Phase 3 Clinical Trial Designed to Enable Potential Resubmission of New Drug Application of Reproxalap in Dry Eye Disease CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
ALDEYRA THERAPEUTICS, INC. Stock Aldeyra Therapeutics, Inc.
 234M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 108B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 104B
ARGENX SE Stock argenx SE
 22.33B -
BIONTECH SE Stock BioNTech SE
 22.19B -
GENMAB A/S Stock Genmab A/S
 18.69B
  1. Stock Market
  2. Equities
  3. ALDX Stock
  4. Charts Aldeyra Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW